Sally Furniss
Well-known member
Domestic vaccine against influenza A / H1N1 / may appear in Russia in early September - WHO
22/06/2009 22:34:00
ST PETERSBURG, June 22. Said. ITAR-TASS Nikolay Krupenik. Domestic vaccine against influenza A / H1N1 / "may appear in Russia in mid-August to early September." This was the head of the National Center for Influenza World Health Organization / WHO / Academician Oleg Kiselev made today at a press conference in St. Petersburg Regional Center of ITAR-TASS.
Necessary biomaterials - candidate vaccine strains for the development of "antidote" - have been transferred through the relevant WHO major research and manufacturing centers, said Kiselev. This, for example, the Central Research Institute of Epidemiology Rospotrebnadzor, virological Center for the Defense Ministry, Petersburg Institute - an experimental medicine, vaccines and serums, as well as enterprise FSUE Mikrogen.
"Professionals" Mikrogena, in particular, this will quickly expand the work on the virus as industrial producers of future antiviral drugs. In parallel, at the Research Institute of Influenza conducted "laboratory test strains and preparation of documentation for clinical trials experienced a series of preparations for volunteers," - noted director of the National Influenza Center WHO.
The drug, triazaverin, developed Ural scientists include in the list of medicines to combat the virus influenza A / H1N1 /. This was told to journalists the President of the Government of Sverdlovsk Region Viktor Koksharov, who attended the meeting of the Governmental Commission on Health in Moscow. "This statement was made at the meeting, Deputy Minister for Health and Social Development Veronika Skvortsova. According to her" triazaverin "will become an alternative to expensive imported drugs. Veronika Skvortsova also noted that the drug has since the beginning of next year can be launched into serial production, which is in the territory of Sverdlovsk region ", - told Victor Koksharov.
The drug, scientists have developed a Institute of Organic Synthesis, Ural Branch, Russian Academy of Sciences. "Triazavirin" was created as a medicine against the strain of H5N1, a bird flu. However, in preclinical testing against strain A / H1N1 /, which has been in the collection of the Russian Research Institute of Influenza, he has shown to be effective in respect of the virus. The first batch of drugs already available in the Ural Pharmaceutical Industry "Medsintez" and going through a stage of clinical research. The first stage of testing already completed. 45 volunteers from St. Petersburg, which at the time of the study were healthy, taking drugs, and tests showed that it was harmless to humans. Now pass the test "triazaverina" for animals that are infected with influenza virus A/H1N1 / and, subsequently, will study how the drug to sick people.
http://www.itartass.ur.ru/news/?id=47139
22/06/2009 22:34:00
ST PETERSBURG, June 22. Said. ITAR-TASS Nikolay Krupenik. Domestic vaccine against influenza A / H1N1 / "may appear in Russia in mid-August to early September." This was the head of the National Center for Influenza World Health Organization / WHO / Academician Oleg Kiselev made today at a press conference in St. Petersburg Regional Center of ITAR-TASS.
Necessary biomaterials - candidate vaccine strains for the development of "antidote" - have been transferred through the relevant WHO major research and manufacturing centers, said Kiselev. This, for example, the Central Research Institute of Epidemiology Rospotrebnadzor, virological Center for the Defense Ministry, Petersburg Institute - an experimental medicine, vaccines and serums, as well as enterprise FSUE Mikrogen.
"Professionals" Mikrogena, in particular, this will quickly expand the work on the virus as industrial producers of future antiviral drugs. In parallel, at the Research Institute of Influenza conducted "laboratory test strains and preparation of documentation for clinical trials experienced a series of preparations for volunteers," - noted director of the National Influenza Center WHO.
The drug, triazaverin, developed Ural scientists include in the list of medicines to combat the virus influenza A / H1N1 /. This was told to journalists the President of the Government of Sverdlovsk Region Viktor Koksharov, who attended the meeting of the Governmental Commission on Health in Moscow. "This statement was made at the meeting, Deputy Minister for Health and Social Development Veronika Skvortsova. According to her" triazaverin "will become an alternative to expensive imported drugs. Veronika Skvortsova also noted that the drug has since the beginning of next year can be launched into serial production, which is in the territory of Sverdlovsk region ", - told Victor Koksharov.
The drug, scientists have developed a Institute of Organic Synthesis, Ural Branch, Russian Academy of Sciences. "Triazavirin" was created as a medicine against the strain of H5N1, a bird flu. However, in preclinical testing against strain A / H1N1 /, which has been in the collection of the Russian Research Institute of Influenza, he has shown to be effective in respect of the virus. The first batch of drugs already available in the Ural Pharmaceutical Industry "Medsintez" and going through a stage of clinical research. The first stage of testing already completed. 45 volunteers from St. Petersburg, which at the time of the study were healthy, taking drugs, and tests showed that it was harmless to humans. Now pass the test "triazaverina" for animals that are infected with influenza virus A/H1N1 / and, subsequently, will study how the drug to sick people.
http://www.itartass.ur.ru/news/?id=47139
